Akmaz Berdel, Zipfel Nina, Bal Roland A, Rensing Benno J W M, Daeter Edgar J, van der Nat Paul B
Department of Value-Based Healthcare, Sint Antonius Hospital, Nieuwegein, The Netherlands.
Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
BMJ Open Qual. 2019 Nov 7;8(4):e000716. doi: 10.1136/bmjoq-2019-000716. eCollection 2019.
As process measures can be means to change practices, this article presents process measures that impact on outcome measures for surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) within value-based healthcare.
Desk research and observations of patient trajectories were performed to map the processes involved in TAVR and SAVR. Semistructured interviews were conducted with healthcare professionals (n=8) and patients (n=2) to explore which processes were most important in relation to a standard set of outcome measures that was already monitored. Additionally, open interviews (n=2) were held to prioritise results. A focus group was performed for validation of the formulated process measures. Numerical data for these measures was not collected.
Process maps of the full cycle of care of TAVR and SAVR treatments in theory and in practice were developed. 28 processes were found important by interview participants due to their expected impact on patient-relevant outcomes. Seven processes were prioritised to be most important and were formulated into 12 process measures for both TAVR and SAVR: 'Number of times that deficient information provision to SAVR patients causes negative outcomes', 'Type of TAVR/SAVR prosthesis', 'Brand of TAVR prosthesis', 'Number of times the frailty score of a TAVR/SAVR patient >75 years is measured', 'Time between TAVR/SAVR surgery indication and surgery', 'Number of times that anticoagulants are stopped within 3 days before surgery', 'Time in hours between TAVR/SAVR surgery and permanent pacemaker implantation' and 'Percentage of standardised pain measurements'.
This study proposes an addition of select process measures to standard sets of outcome measures to improve healthcare quality. It illustrates a clear method for identifying process measures with impact on health outcomes in the future.
由于过程指标可以作为改变医疗行为的手段,本文介绍了在基于价值的医疗保健中,对外科主动脉瓣置换术(SAVR)和经导管主动脉瓣置换术(TAVR)的结果指标有影响的过程指标。
通过案头研究和对患者病程的观察,梳理TAVR和SAVR所涉及的流程。对医疗保健专业人员(n = 8)和患者(n = 2)进行了半结构化访谈,以探讨哪些流程对于已监测的一组标准结果指标最为重要。此外,还进行了开放式访谈(n = 2)以对结果进行优先级排序。开展了一次焦点小组讨论以验证所制定的过程指标。未收集这些指标的数值数据。
绘制了理论和实践中TAVR和SAVR治疗全程护理的流程图。访谈参与者发现28个流程因其对患者相关结果的预期影响而很重要。七个流程被确定为最重要的流程,并被制定为TAVR和SAVR的12个过程指标:“向SAVR患者提供不足信息导致负面结果的次数”、“TAVR/SAVR假体类型”、“TAVR假体品牌”、“对年龄>75岁的TAVR/SAVR患者进行衰弱评分的次数”、“TAVR/SAVR手术指征与手术之间的时间”、“术前3天内停用抗凝剂的次数”、“TAVR/SAVR手术与永久起搏器植入之间的小时数”以及“标准化疼痛测量的百分比”。
本研究建议在标准结果指标集中增加选定的过程指标,以提高医疗质量。它阐明了一种在未来识别对健康结果有影响的过程指标的清晰方法。